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Abstract:  We  explore the diagnostic potential of imaging endogenous 
fluorophores using two photon microscopy and fluorescence lifetime 
imaging (FLIM) in human skin with two spectral detection channels. 
Freshly excised benign dysplastic nevi (DN) and malignant nodular Basal 
Cell Carcinomas (nBCCs) were excited at 760 nm. The resulting 
fluorescence signal was binned manually on a cell by cell basis. This 
improved the reliability of fitting using a double exponential decay model 
and allowed the fluorescence signatures from  different cell populations 
within the tissue to be identified and studied. We also performed a direct 
comparison between different diagnostic groups. A statistically significant 
difference between the median mean fluorescence lifetime of 2.79 ns versus 
2.52 ns (blue channel, 300-500 nm) and 2.08 ns versus 1.33 ns (green 
channel, 500-640 nm) was found between nBCCs and DN respectively, 
using the Mann-Whitney U test (p < 0.01). Further differences in the 
distribution of fluorescence lifetime parameters and inter-patient variability 
are also discussed. 
© 2011 Optical Society of America 
OCIS codes:  (170.1870) Dermatology; (170.6920) Time-resolved imaging; (170.6510) 
Spectroscopy, tissue diagnostics; (180.4315) Nonlinear microscopy; (300.6410) Spectroscopy, 
multiphoton; (170.3880) Medical and biological imaging. 
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1. Introduction 
Human skin contains a number of naturally occurring fluorophores that can be used as a 
potential source of contrast for non-invasive imaging without requiring the use of exogenous 
contrast agents. These fluorophores include collagen, elastin, melanin, keratin, porphyrins, 
NAD(P)H and flavins [1]. Fluorescence intensity can be measured using two photon 
excitation to provide optically sectioned images with sub-cellular resolution and allow tissue 
morphology to be studied and quantified in detail [1–3]. The fluorescence can also be resolved 
with respect to emission wavelength [4,5] and fluorescence lifetime [5–8] to provide further 
contrast between different tissue types. Such spectral ratiometric or lifetime measurements are 
insensitive to experimental measurement parameters such as laser excitation power, photon 
collection efficiency or detector sensitivity. This allows absolute measurements of 
spectroscopic parameters to be compared within and between samples. 
The intracellular fluorophore NAD(P)H is integral to cellular metabolism and by 
measuring its fluorescence emission spectrum [9] and lifetime [10], changes in the metabolic 
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[11] have been correlated with the dysplastic transformation associated with melanoma skin 
cancer. This ability for autofluorescence imaging to assess both the morphology and metabolic 
[3] state of tissue non-invasively distinguishes this technique from other non-invasive imaging 
modalities. 
In this paper we describe the analysis of fluorescence intensity and FLIM images from 
freshly excised human skin samples of dysplastic nevi (DN) and nodular Basal Cell 
Carcinomas (nBCCs). We use a modified commercial two-photon tomograph [12] that 
collects the fluorescence signal into two spectrally and temporally resolved channels (‘blue 
channel’, 380-500 nm and ‘green channel’, 500-640 nm). For an excitation wavelength of 760 
nm, we expect intracellular fluorophores in the blue channel to be dominated by fluorescence 
from NAD(P)H with its emission spectral peak between 450 and 470 nm [4,13] and the green 
channel to be dominated by melanin autofluorescence (spectral peak at 550 nm [4,14]), with 
potential contributions from flavins (peak at 525 nm [4,13]). 
In two photon tomography of tissue the excitation beam power is restricted to prevent 
damage to the sample and acquisition times in vivo are minimized to avoid motion artifacts. 
As a consequence, the limited number of photons collected per pixel can be inadequate to 
reliably calculate fluorescence lifetimes per pixel using multi-exponential decay models. 
Although a single exponential decay model requires the fewest photons to fit reliably, it is 
desirable to employ more complex decay models because the fluorescence from skin 
originates from multiple fluorescent species, each of which are themselves likely to exhibit 
complex decay profiles. We address this issue by spatially binning all the photons for each 
cell within each image. This increases the number of photons available for fitting and allows a 
double exponential decay model to be fitted to the data. The work presented here demonstrates 
the potential to discriminate between different types of cutaneous lesions (specifically DN and 
nBCCs) by analyzing the tissue autofluorescence at the individual cell level with respect to 
both spectral and lifetime parameters. The two lesion types were selected to maximize our 
ability to detect differences in the spectroscopic parameters, and to determine the utility of our 
multi-spectral FLIM approach for future studies involving more clinically meaningful 
comparisons. 
2. Equipment 
Two photon tomographic imaging was performed using a modified DermaInspect® (JenLab 
GmbH, Jena, Germany), which is CE marked for clinical imaging of skin. A mode-locked 80 
MHz Ti:sapphire laser (Spectra Physics®, CA, USA) equipped with a prism based chirp 
compensation unit (DeepSee module, Spectra Physics®) was used as the excitation laser 
source. The laser has a tuning range between 710 and 920 nm and the excitation power was 
attenuated to a maximum of 50 mW at the sample. The excitation beam passes through two 
galvoscanners, allowing scanning in the x-y plane, before being focused into the sample by a 
40 × /1.4NA oil immersion objective. The microscope objective facilitated a working depth up 
to 200 µm with a lateral resolution of <1 µm and an axial resolution of <2 µm. 
The emitted fluorescence passed through a 640 nm short pass dichroic filter (Chroma 
Technology Corp., Vermont, USA), a BG39 spectral filter (Präzisions Glas & Optik GmbH, 
Germany) and was spectrally separated by a long pass 500 nm dichroic beam splitter (AHF 
Analysentechnik AG, Germany). It was then detected by two H7722P-40 PMTs detectors 
(Hamamatsu Photonics K.K., Japan), each protected by another BG39 filter. The two PMTs 
therefore collected fluorescence in 380-500 nm (‘blue’) and 500-640 nm (‘green’) spectral 
channels. Fluorescence lifetimes were determined using time correlated single photon 
counting (TCSPC) implemented with 256 time bins using an SPC-830 module (Becker & 
Hickl GmbH, Germany). The gain and cooling of the PMT detectors was controlled by a 
DCC-100 card (Becker & Hickl GmbH). 
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The tissue was collected from patients attending the Department of Dermatology at Imperial 
College Healthcare NHS Trust. The study was ethically approved by the regional ethics 
committee (Ref 09/H0706/28) and patients gave written informed consent to participate unless 
they met the following exclusion criteria; age 18 years or less, in state custody, carrying a 
blood borne infection, having a photosensitive skin disorder, or pregnancy. Patients with 
clinically suspected nBCCs and DN already scheduled for excision were recruited. All clinical 
diagnoses were confirmed histologically following imaging. 
Freshly excised lesions were rinsed with Hanks Balanced Salt Solution (HBSS) buffer 
without phenol red, calcium or magnesium (Gibco®, Invitrogen, CA, USA) and placed on 
damp gauze in an inverted glass bottomed petri dish containing a 170 µm cover slip (Matek®, 
MA,USA). This was attached to a metallic ring using adhesive and coupled magnetically to 
the DermaInspect®. A drop of water was placed between the tissue and the cover slip and a 
drop of Immersol 518F (Carl Zeiss Ltd, Germany) was placed between the cover slip and the 
objective. 
4. Imaging protocol 
Images were acquired as soon as possible (typically within 15 minutes) until a maximum of 
2.5 hours post excision. All images were taken using an excitation wavelength of 760 nm and 
the excitation power was manually adjusted depending on the imaging depth. Images from 
several depths and often more than one field of view were taken from each lesion. Each FLIM 
image of 128 × 128 pixels was acquired over 25.5 s. The pixel size was between 1.38 µm and 
3.28 µm, depending on the size of the scanned region. The instrument response function (IRF) 
was recorded each day in the blue spectral channel using the second harmonic generation 
(SHG) signal obtained from urea crystals (>98% Urea, Sigma-Aldrich®,USA). 
5. Data analysis 
5.1. Regions of interest 
Regions of interest (ROIs) corresponding to each cell in every image were manually defined 
with the help of software written in Labview 7.1 (National Instruments®, TX, USA), see Figs. 
1a and b). The data were then batch processed to calculate the spectroscopic parameters for 
every ROI using an algorithm written in Matlab® (R2010b, The Mathworks Inc., USA). 
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Fig. 1. a) example autofluorescence image obtained from a dysplastic nevus ex vivo. Scale bar 
50 µm. b) shows the same data as a) but with the manually defined cellular regions of interest 
overlaid in green. c-top) shows the spatially integrated fluorescence decay profile obtained in 
the blue channel from a defined cellular region of interest (black dots) together with the 
instrument response function (blue) and double exponential fit to the data (green). c-bottom) 
shows the weighted residuals of the fit to the experimental data. 
#153555 - $15.00 USD Received 30 Aug 2011; revised 7 Oct 2011; accepted 13 Oct 2011; published 10 Nov 2011
(C) 2011 OSA 1 December 2011 / Vol. 2,  No. 12 / BIOMEDICAL OPTICS EXPRESS  32985.2. Fluorescence lifetime model 
Photons within each ROI were first summed at each time point. The double-exponential decay 
model (Eq. (1) was then fitted to the fluorescence decay from each ROI (i.e. each cell) in each 
channel; see the example shown in Fig. 1c: 
 
mod 1 1 2 2 () (, , ) (, , )
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= ⋅
−
   (1) 
Here tot I is the total number of photons,  p T  is the pulse repetition period,  1 f  (0< 1 f <1) is the 
fraction of photons originating from the first ( 1 τ ) decay component ([15], page 192) and  2 f  = 
(1 − 1 f ) is the proportion from the second decay component. The function  (, , ) p Dt T τ  is the 
normalized exponential decay whose integral over the measurement interval Tp equals 1 [16]. 
We note that the factor( )
1 / 1
p T e
τ − − −   in  Eq. (1)  allows proper treatment of incomplete 
exponential decays [17]. 
Due to the Poisson nature of the photon shot noise, the fitting error function 
2 χ  was 
chosen in the following form (see also [15], page 119): 
 
2
2
1
[ () () ]
()
bins N predicted k measured k
k
predicted k
I tI t
It
χ
=
−
=∑    (2) 
where Nbins is the number of TCSPC time bins (Nbins = 256 for our system), {} k t  is the discrete 
time at the center of each time bin, and Imeasured(tk) is the number of photons in the k-th time 
bin (ROI sum). Equation (2) is the model-weighted form of
2 χ  that avoids potential divisions 
by zero. 
The predicted fluorescence decay Ipredicted(tk) in Eq. (2) can be calculated by convolving the 
fluorescence decay model (1) with the measured IRF ([15], page 103). In order to achieve this, 
we also took two further steps to ensure the comparability of the measured data to the 
predicted signal. 
In the first step, the IRF was pre-processed by subtracting the horizontal long-time 
asymptote or ‘pedestal’ and normalized to have unit area. It is believed that the main 
contributing factors to this pedestal were a signal-independent contribution from background 
noise (stray light, electronic noise and cosmic rays) and a signal-dependent contribution from 
after-pulsing (caused by a delayed response of the PMT to a small fraction of preceding laser 
pulses) ([18], page 233). We compensate for these effects by calculating an offset for our 
decay model, which is described in more detail below. 
Although the daily measurement of the IRF using SHG is only recorded in the blue 
channel, the IRFs of the two detection channels were sufficiently similar for us to apply the 
same IRF to the green channel. This was verified through separate measurements of each 
channel. However, it was necessary to include a temporal shift of the IRF for both channels in 
order to achieve a reasonable fit. This shift was determined in each channel by fitting all of the 
experimental data with a specific temporal shift and calculating the average 
2 χ  across all of 
the ROIs. This was then repeated over a range of shift values and the shift providing the 
minimum (global) average 
2 χ  was selected and applied to the IRF. The model decay Imod(tk) 
was then convolved with the corrected IRF ([15], page 103) and we therefore model the 
function to which the experimental data are fitted, Ipredicted(t), as 
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where H is the height of signal’s pedestal (defined as “per bin” value). We chose to define H 
as 
  exp(1 ) B
bins
r
H pt r F
N
= −+   (4) 
where r is the after-pulsing coefficient defined as the ratio of the sum of after-pulsing counts 
to the total intensity of the (background-corrected) signal, pB is the power of the background 
noise (with dimensions counts/bin/pixel/second), texp  is the exposure time used for data 
acquisition and F is the total number of photons in the decay. The values of pB and r used 
during fitting were determined experimentally in each channel from the measured IRF and 
corresponding dark images (acquired with the excitation power set to zero). In order to 
correctly include the tail of the decay from earlier excitation pulses, the IRF convolution in (3) 
was applied to the model signal composed of two consecutive identical model decays  mod() k It  
representing the sample’s response to all preceding laser pulses and the current pulse. 
The fitting algorithm used the Matlab “lsqnonlin” function to find the four fitting 
parameters
2
112 { , , , } argmin[ ] tot fitted If ττ χ = , where the fitting error χ
2 is described by Eq. (2) 
and the fitting model is described by Eqs. (3) and (4). The parameters for the fluorescence 
intensity and lifetimes were defined for each ROI in each spectral channel. Individual decays 
with fewer than 900 photons per ROI per channel were excluded from the analysis. Mean 
fluorescence lifetimes were calculated from the fitted parameters using 
11 1 2 (1 ) mean ff ττ τ = +− . The relative fluorescence signal in the blue (b) and green (g) spectral 
channels (RF) was calculated for each region of interest (ROI) using the total emitted 
fluorescence (F) in each channel, i.e. 
 
b
b
bg
g
g
bg
F
RF
FF
F
RF
FF
=
+
=
+
   (5) 
We found that these parameters were useful in comparing the difference in emission 
spectrum between different populations of cells (Fig. 5 below). 
5.3. Statistics 
Statistical analysis of the results was performed using SPSS 18 (SPSS Inc. IL,USA). 
6. Results 
Excised lesions from 4 males and 3 females with a mean age of 56 (range 35 – 78 years) were 
included in our study. Lesions were excised from the scalp, face, chest, thigh and lower leg. 
From the resulting 49 FLIM images, 1180 ROIs were defined manually (614 nBCCs, 566 
DN). The median (25th, 75th percentile) total photons collected per ROI were 8775 (5264, 
17130) in the blue channel and 6061 (3742, 10157) in the green channel. 
6.1. Fluorescence intensity imaging 
Figure 2 illustrates typical image sets taken at different depths from DN and nBCCs. The 
images taken from the DN demonstrate normal epidermal architecture. The acellular stratum 
corneum, the most superficial layer of the epidermis, fluoresces brightly due to the high 
concentration of keratin present. Keratinocytes become clearly visible from 40 µm and cells 
reduce in size and increase their nuclear to cytoplasmic ratio with depth. Images taken from a 
depth of 60 µm show brightly fluorescent cells in the green channel, which we attribute to  
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Fig. 2. a) Schematic of the emission spectra from intracellular fluorophores. Adapted from 
Palero et al. [4]. b) dermatoscopic image of a dysplastic nevus (scale bar 1 mm). c) 
corresponding depth resolved fluorescence intensity image stacks for the two spectral channels 
(scale bar 50 µm). d) macroscopic image of a nodular basal cell carcinoma (scale bar 5 mm). e) 
corresponding depth resolved fluorescence intensity image stacks (scale bar 50 µm). We note 
that the feint striping artifact in the deeper images in e) is due to unavoidable stray light from 
the computer monitor. 
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epidermis. 
Although the same cells are slightly brighter in the blue channel, the contrast is lower. This 
is consistent with measurements of melanin’s emission spectrum, which peaks with a broad 
maximum  around  ~550-620  nm  [11,14].  Between  75  and  100  µm  the  reduced  cellularity 
denotes the presence of the dermal layer in areas of the image. 
The normal architecture is not present in the images taken from the ulcerated nBCC (Fig. 2 
d and e). Monomorphic cells can be seen throughout all layers of the skin and there is no 
reduction in size and no increase in nuclear to cytoplasmic ratio with depth. Fluorescence 
from the collagen and elastin fibers can also be seen in the deepest image at 100 µm, with 
potential contributions from SHG in the blue channel 
6.2. Analysis of fluorescence lifetimes 
A double exponential lifetime was fitted to each ROI (cell) for each spectral channel for all 
images  containing  cells.  Figure  3  shows  normalized  histograms  for  τ1  (short  lifetime  
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Fig. 3. Histograms of the fluorescence decay parameters calculated on a per-cell basis for the 
dysplastic  nevi  (DN)  and  nodular  Basal  Cell  Carcinoma  (nBCC)  specimens.  a  and  b) 
histograms of τ1, c and d) histograms of τ2 and e and f) histograms of τmean. a,c,e) fluorescence 
lifetimes from the blue channel (left column) and b,d,f) fluorescence lifetimes from the green 
channel (right column). 
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diagnosis. 
The  τ1  histograms (Figs. 3 a and b) show similar features in both channels for each 
diagnosis. The lifetimes from nBCC cells predominantly fall below 500 ps for both channels. 
The lifetimes from DN have a bimodal distribution with peaks centered around 100-150 ps 
and 575-600 ps. The peak with the shorter lifetime dominates in the green channel. 
The histograms for the longer lifetime component, τ2, (Figs. 3 c and d) show similar 
distributions between the diagnostic groups in the blue channel. In the green channel however, 
the distribution from nBCCs cells are skewed towards longer lifetimes with a peak near 3000 
ps and the DN lifetimes demonstrate a bimodal distribution with a larger peak near 1750 ps. 
Table 1. Summary of the 25th, median and 75th percentile for all of the spectroscopic 
parameters for each spectral channel (blue or green) for each cell. Blue detection channel 
<500 nm and green detection channel >500 nm. 
Index  Channel  Diagnosis 
Percentile 
25  50  75 
τmean (ps)  Blue  nBCC  2459  2786  3350 
   DN  2072  2516  2911 
   Green  nBCC  1783  2085  2930 
   DN  810  1334  2807 
f1  Blue  nBCC  0.31  0.34  0.37 
   DN  0.37  0.40  0.44 
   Green  nBCC  0.38  0.42  0.47 
   DN  0.42  0.46  0.59 
τ1 (ps)  blue  nBCC  215  318  414 
   DN  147  279  534 
   Green  nBCC  173  263  354 
   DN  116  208  494 
τ2 (ps)  Blue  nBCC  3692  4120  4829 
   DN  3491  4032  4577 
   Green  nBCC  3044  3594  4705 
   DN  1843  2945  4669 
RF  —  nBCC  0.57  0.60  0.64 
   DN  0.53  0.62  0.66 
The histograms of mean decay time (Figs. 3 e and f)  show features similar to those 
described above for τ2. This reflects the dominance of the longer lifetime component in the 
collected fluorescence (lower f1, see also Table 1). Since the mean decay time is not normally 
distributed, we have calculated the 25th, median and 75th percentile for each calculated 
parameter in each channel and this is shown in Table 1. 
The null hypotheses of “there is no difference in the median mean lifetimes between DN 
and nBCCs” and “there is no difference in the distribution of the mean lifetimes between DN 
and nBCCs” were tested for each spectral channel using a Median Test and a Mann-Whitney 
U test respectively. The null hypothesis was rejected in each case with p<0.01. 
To explore the trend in lifetimes further, the data from the green channel (plotted in Figs. 3 
b and d) can be represented as scatter plots showing τi against its fractional component fi (Figs. 
#153555 - $15.00 USD Received 30 Aug 2011; revised 7 Oct 2011; accepted 13 Oct 2011; published 10 Nov 2011
(C) 2011 OSA 1 December 2011 / Vol. 2,  No. 12 / BIOMEDICAL OPTICS EXPRESS  33034 a and b). Figure 4a demonstrates that the shorter lifetime peak at 100-150 ps seen in Fig. 3b 
for DN has a large range in fractional component f1. In contrast, the longer lifetime peak 
between 575 and 600 ps arise from cells with similar fractional components. This same feature 
can also be seen comparing Fig. 3d with Fig. 4b for τ2 versus f2. The scatter plot of τ1 versus τ2 
(Fig. 4c) confirms that the cells forming the short lifetime peak in the histogram of τ1 also 
form the short lifetime peak in the histogram of τ2. This suggests that there are two 
populations of cells in DN: one with consistent τ1, τ2 and f1, and the other with consistent τ1 
and τ2 but with a variable f1. We tentatively attribute these two populations to melanin free 
keratinocytes and to melanin containing keratinocytes and melanocytes, see discussion section 
below. This feature was not seen for the cells from nBCCs. 
(d) (c)
(b) (a) τ2 (ps)  
ƒ1
τ1(ps)    
τ1 (ps)   Blue τmean (ps)     
ƒ2
G
r
e
e
n
τ
m
e
a
n
 
(
p
s
)
 
 
 
 
 
τ
2
(
p
s
)
 
 
 
Fig. 4. a) shows f1 correlated against τ1 and b) shows f2 correlated against τ2. c) show s τ 1 
correlated against τ2. a-c) show data obtained in the green channel. d) shows τmean from the blue 
and green spectral channels plotted against each other. This plot demonstrates that the 
distribution of mean lifetimes from cells for each diagnostic group are partially separated, with 
a tendency for shorter lifetimes in both channels for DN cells. The dashed line is x = y. 
Figure 4(d) and Table 1 show that different values of τmean have been calculated for the 
blue and green channels. This reflects the additional spectroscopic information obtained by 
collecting the fluorescence signal into two channels with each channel dominated by 
fluorescence from different fluoropohores. The positive correlation between τmean in the two 
spectral channels is expected because the broad emission spectra of some tissue fluorophores 
emit into both detection channels. 
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was plotted against τmean for DN, with the color of each point representing each FOV imaged, 
see Figs. 5a and b. These plots show clustering of points derived from different FOV, both 
between different patients and between FOV within the same lesion in the same patient. The 
inter-FOV variability for patient DN2 is particularly evident (tan and purple points in Figs. 5a 
and b). This clustering was not prominent for nBCCs (see Figs. 5c and d). Our sample size 
was too small to assess or quantify the nature of the inter- and intra-patient variability of the 
fluorescence parameters. 
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(d)
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Blue τmean (ps)     
Blue τmean (ps)     
Green τmean (ps)     
Green τmean (ps)     
 
Fig. 5. a and b) relative fluorescence emission intensity plotted against mean fluorescence 
lifetime in each channel respectively for the DN specimens. Different colors are used to 
represent each patient and each FOV. c and d) shows the same as a and b) but for the nBCC 
data. 
7. Discussion 
Methods of analysis of multiphoton excited TCSPC lifetime data of skin used in the literature 
range from using pixel sampling [5] to calculating a lifetime histogram of the entire image [7]. 
Such methods have potential drawbacks. Manually sampled pixels are subject to selection bias 
and obtaining sufficient numbers of photons in a single pixel for an accurate lifetime fit using 
a double exponential decay models is difficult. To address this, photon counts can be 
increased by binning (or smoothing) the image. However, this decreases the spatial 
information, and with the selected pixel potentially containing data from outside the targeted 
tissue component. Fitting regions larger than a single cell decreases the sensitivity for 
detecting intercellular changes, especially in tissue with heterogenous cell populations. 
We believe that our method of binning photons into ROI corresponding to cells increases 
the number of photons available for accurately fitting double exponential lifetime decays 
whilst maintaining the ability to detect heterogenous cell populations within images. After 
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section 5, sufficient photons were available to fit double exponential lifetimes to cells decays 
with a mean ± s.d. reduced χ
2 of 1.27 ± 0.3 in the blue channel and 1.13 ± 0.2 in the green 
channel. 
Our results show similar morphological features to those described previously from multi-
photon fluorescence intensity imaging of cutaneous malignancies [19,20]. A qualitative 
assessment of the morphological differences was also made between images taken from the 
two diagnostic groups. Although morphological differences could be seen between the two 
diagnostic categories (described above), a preliminary automated analysis of morphological 
features using the manually selected ROI boundaries was unable to highlight these differences 
(data not shown). 
We have shown that, despite the limited sample size in this study, statistically significant 
differences were established between the medians and distributions of mean lifetimes between 
the two diagnostic groups examined. From the histograms, it can be seen that this difference is 
more pronounced in the green channel. Whilst the differences seen between the spectral 
channels provide some information as to the underlying fluorophore mix in each diagnostic 
category, the number of channels is insufficient to definitely attribute our findings to 
individual fluorophores. An exception to this is the contribution of melanin, which can be 
determined on the basis of its very short lifetime component [14,21] and its dominance in the 
green channel, see Fig. 3(b). 
Recent work has shown that it is possible to distinguish malignant melanoma from benign 
melanocytic lesions such as naevi through changes in the fluorescence emission spectrum of 
melanin near to 600 nm [22,23], which is attributed to differences in the relative abundances 
of eumelanin and pheomelanin in these tissues. The 2-channel instrument reported here would 
therefore not be sensitive to these changes, as all fluorescence over 500 nm is collected into 
the ‘green’ channel (500-640 nm). However, future work employing an instrument with more 
than two spectral channels would be able to investigate this point. 
The fluorescence lifetimes of cells within nBCCs overlap with the distribution observed 
for DN but tend to have a longer fluorescence lifetime. Since the nBCCs were not pigmented, 
the observed fluorescence is expected to be predominantly due to NAD(P)H and the median τ1 
exponential lifetime components observed (median values: blue τ1 = 318 ps, green τ1 = 263 ps) 
are in reasonable agreement with measurements of NAD(P)H by other groups [10,24]. 
However, the measured τ2 component (median values: blue τ2 = 4120 ps, green τ2 = 3594 ps) 
is almost a factor of two longer than that observed in the cited previous work, which may be 
attributed to many differences including species, tissue type, decay fitting procedure, presence 
of additional fluorescent species or in vivo versus ex vivo measurement. 
One of the most striking results seen is the recurrence of two distinct populations of cells 
seen in DN, as demonstrated by the bimodal peaks seen in many of the histograms in Fig. 3. 
Biologically a DN would consist of more than one cell population—keratinocytes  and 
melanocytes. However, we believe the two populations seen in the histograms are more likely 
to represent melanin containing and non-melanin containing cells (mostly keratinocytes), 
since a melanocyte and a melanin containing keratinocyte would be very difficult to 
distinguish spectroscopically. Another interesting finding, shown most clearly in Fig. 4, are 
numerous DN cells containing a fluorophore with a similar short lifetime component but 
having a large spread in its fractional contribution. We speculate that this is due to the varying 
amounts of melanin found within the cells from DN. 
We observe inter- and intra-patient variability for the fluorescence lifetime of cells as 
shown in Fig. 5. Part of this variability arises from the shot noise on the acquired decay data. 
To estimate the effect of shot noise, we simulated 300 double exponential decays using the 
measured IRF and the random Poisson noise generation function in Matlab (poissrnd). The 
parameters for the simulated decay were chosen to represent a typical skin cell and were f1 = 
0.4, τ1 = 300 ps and τ2 = 3800 ps. Each of the simulated decay curves was fitted using the 
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deviations were σf1 = 0.011, στ1 = 13 ps and στ2 = 123 ps. The corresponding error for the 
mean lifetime was 60 ps. It can be seen from Fig. 5 that the variability between cells from the 
same FOV are much larger than the estimated error due to shot noise alone. We attribute the 
variability seen in lifetimes of DN to the random sampling of typically heterogenous DN 
architecture by our acquisition protocol. There is a greater heterogeneity in fluorescence 
signature for nBCCs than for DN (Fig. 5 c and d) and this makes it harder to assess whether 
there is significant variation between patients or FOV. 
As NADH is intimately involved in cellular metabolism, the changes in tissue oxygenation 
and supply of metabolites following surgical excision of skin may cause significant changes to 
the NAD(P)H fluorescence over the timescale of our experiments. These changes could 
include an increase in the NAD(P)H fluorescence intensity (measured to be up to 70% in 
mouse skin) and shifts in the fluorescence emission spectrum of ~5 nm [9]. Studies of the 
change in NAD(P)H fluorescence intensity following resection in other tissue types include 
breast tissue, where the fluorescence intensity decreased with time over the first 3–4 hours of 
tissue removal followed by stabilization of the signal [25], and colon, where the NAD(P)H 
signal decayed with a half-life of 118 minutes [26]. 
The fluorescence decay profile can also change with metabolic state and decreases in the 
mean fluorescence lifetime of NAD(P)H upon hypoxia of 18% have been observed in isolated 
hippocampal slices ex vivo [24]. In a recent study on multiphoton excited autofluorescence of 
skin, the same mean fluorescence lifetime (~1000 ps) was obtained from in vivo 
measurements as from ex vivo measurements taken on the same day but an increase in mean 
fluorescence lifetime from ~1000 to ~2000 ns was observed for specimens stored in culture 
media at room temperature over a period of three days post excision. 
Therefore, care must be exercised when interpreting the results of our study. While the rate 
of metabolic changes in human skin will depend on a number of parameters, including e.g. 
temperature and sample species, it is reasonable to assume that there will still be a significant 
contribution from NAD(P)H in autofluorescence data acquired on the timescale of 0-2.5 hours 
after excision as presented here. We would expect any changes in the autofluorescence 
associated with the metabolic state of the tissue to be most evident in the blue spectral 
detection channel, which is dominated by NAD(P)H fluorescence. The green channel should 
be less affected as the fluorescence properties of melanin would not be expected to change 
following excision. Thus the NAD(P)H dominated curves in Figs. 3 (a, c and e) and the 
horizontal position of points in Fig. 4(d) may exhibit a broader spread than would be observed 
in vivo due to the range of observation time points employed in our ex vivo study. In addition, 
some of the inter-patient variability shown in Figs. 5(a and c) may also be due to this effect. 
However, we believe that the key differences observed between nBCC’s and DN remain 
irrespective of potential changes in NAD(P)H fluorescence with metabolic status, due to the 
very different spectroscopic properties of melanin and NAD(P)H. 
8. Conclusions 
We have presented fluorescence intensity and lifetime images obtained from two different 
types of skin lesion ex vivo. The data have been analyzed using an image segmentation 
approach of binning pixels from cellular ROI and fitting to a double exponential fluorescence 
decay model. Dividing the image into ROIs corresponding to individual cells is biologically 
logical, straightforward, relative robust and facilitates automation of the analysis thereafter. 
To probe the spectral-lifetime contrast between different lesion types we have used two 
spectral detection channels. 
We have shown that, by using this methodology, changes in the fluorescence emission 
spectrum and fluorescence lifetime from freshly excised tissue could be observed between DN 
and nBCCs. Using our cellular ROI approach, we were also able to show that there are two 
spectroscopically different populations of cells present in DN, which we tentatively attribute 
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cells, there is a large variation in the relative contribution of melanin to the total fluorescence 
signal. Although the comparison of nBCC to DN is not clinically diagnostically useful, we 
believe that the data shown here demonstrates that multiphoton FLIM has significant potential 
to diagnose and delineate common skin tumors. 
Work has already begun implementing more spectral detection channels and collecting 
data  in vivo. We hope this will be able to quantify the effects of inter and intra-patient 
variability that could not be addressed by the present study and explain the longer τ2 measured 
for NAD(P)H compared to previous literature. As more data are collected, the next challenge 
is to develop the pattern recognition method(s) capable of using all three groups of cell-based 
quantifiers provided by FLIM (relative fluorescence intensity, lifetime and morphology), to 
discriminate between clinically more useful diagnostic groups and/or degrees of dysplasia. 
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